Approval · Notice of Compliance 2725 · 1998
BUSPIREX: Notice of Compliance 2725
Issued April 30, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2725
- Date
- April 30, 1998
- Company
- Technilab Pharma Inc.Mirabel, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Anxiolytic
- Canadian reference product
- BUSPAR (Bristol-Myers Squibb Canada)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BUSPIREX | 02237858 | Cancelled Post Market |
Medicinal ingredients
- BUSPIRONE HCL 10 MG per TAB